The new direct oral anticoagulants such us rivaroxaban, could play an important role in the anticoagulant treatment of patients with paroxysmal nocturnal hemoglobinuria where anticoagulant treatment is complex to run, since they have shown a reduction in serious bleeding complications compared to antithrombotic therapy with classical vitamin k antagonist.
Anticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria / Dragoni, Francesco; Chiarotti, Flavia; Lombardi, Laura; Iori, ANNA PAOLA; Cafolla, Arturo. - In: CLINICAL CASE REPORTS. - ISSN 2050-0904. - STAMPA. - 3:10(2015), pp. 790-2-792. [10.1002/ccr3.342]
Anticoagulant therapy with rivaroxaban in a young patient with paroxysmal nocturnal hemoglobinuria
LOMBARDI, LAURA;IORI, ANNA PAOLA;CAFOLLA, Arturo
2015
Abstract
The new direct oral anticoagulants such us rivaroxaban, could play an important role in the anticoagulant treatment of patients with paroxysmal nocturnal hemoglobinuria where anticoagulant treatment is complex to run, since they have shown a reduction in serious bleeding complications compared to antithrombotic therapy with classical vitamin k antagonist.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
